Showing results (351-360 of 391) with videos related to
Sort By:
Pageof 40
JHEP Reports : Innovation in Hepatology|October 16, 2024
Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseasesEnrique García-Nieto, Juan Carlos Rodriguez-Duque, Coral Rivas-Rivas, et al.The Australasian Journal of Dermatology|July 12, 2023
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish populationA Sahuquillo-Torralba, M Hospital-Gil, E Vilarrasa-Rull, et al.Endocrinologia, Diabetes Y Nutricion|February 10, 2023
GALIPDIA study: Reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of SpainRocío Villar-Taibo, Eva Fernández-Rodríguez, Cristina Tejera-Pérez, et al.International Journal of Clinical Practice|March 9, 2021
Rationale, design and preliminary results of the GALIPEMIAS study (prevalence and lipid control of familial dyslipidemia in Galicia, northwest Spain)Rosa María Argüeso-Armesto, Teresa-Rosalia Pérez-Castro, José Luis Díaz-Díaz, et al.Vaccine|September 2, 2009
Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adultsRodrigo Valera, Hilda María García, Manuel Díaz Jidy, et al.International Journal of Technology Assessment in Health Care|May 4, 2021
Postlaunch evidence-generation studies for medical devices in Spain: the RedETS approach to integrate real-world evidence into decision makingPedro Serrano-Aguilar, Iñaki Gutierrez-Ibarluzea, Pilar Díaz, et al.International Journal of Cancer|February 4, 2020
Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC studyDelphine Casabonne, Yolanda Benavente, Julia Seifert, et al.Ecology|April 28, 2018
A morphological database for 606 Colombian bird speciesPaola Montoya, Mailyn A Gonzalez, Elkin A Tenorio, et al.United European Gastroenterology Journal|July 30, 2020
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's diseaseIago Rodríguez-Lago, Javier Del Hoyo, Alexandre Pérez-Girbés, et al.Nature Communications|August 7, 2023
Urbanisation generates multiple trait syndromes for terrestrial animal taxa worldwideAmy K Hahs, Bertrand Fournier, Myla F J Aronson, et al.Pageof 40